← FDA Drug Approvals (Drugs@FDA)
PALBOCICLIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AIZANT DRUG RESEARCH SOLUTIONS PVT LTD · Approved 2022-03-04
Drug application
- FDA Application #
ANDA213152- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PALBOCICLIB
- Generic name
- Palbociclib
- Active ingredients
- PALBOCICLIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- AIZANT DRUG RESEARCH SOLUTIONS PVT LTD
- First approval
- 2022-03-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown